Pharmaceutical Representative Training
FEBRUARY 4, 2021
As the healthcare industry evolves with novel and innovative therapies, it brings the need for highly specialized conversations with healthcare providers (HCPs) and key opinion leaders (KOLs). While the sales force is still a crucial part of any pharmaceutical company, the demand for Medical Affairs teams continue to rise.
Contrarian Sales Techniques
FEBRUARY 20, 2023
Are you ready to explore the fascinating world of Medical Science Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 19, 2022
That statement, coined by one of my colleagues at Healthware MedComms , summarises the changing state of communications between pharmaceutical organisations and their healthcare provider (HCP) stakeholders.
Referral MD
FEBRUARY 28, 2025
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medical science advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements. What is Digital Patient Intake?
PM360
NOVEMBER 27, 2023
For example, insights from healthcare providers (HCPs) might be filtered through a medical science liaison’s interpretations, leading to gaps in the captured requirements. However, these roles are not immune to biases or misinterpretations, which can result in overlooked end-user requirements.
Impetus Digital
AUGUST 12, 2022
Kaitlin joined Novartis Canada in 2017 as a Medical Science Liaison in Immunology, prior to becoming a Medical Advisor in the Immunology Franchise in 2021, where she was responsible for chronic urticaria, psoriasis, and food allergy. Book a Consultative Demo.
Pharmaceutical Technology
NOVEMBER 3, 2022
As a result, healthcare providers need to rely on generic manufacturers, but there are only a few who make them, he explains. In the US, dobutamine is produced by Baxter Healthcare, a subsidiary of Baxter International, and Hospira, a manufacturer of generic injectables acquired by Pfizer.
Expert insights. Personalized for you.
52 
Let's personalize your content